With the global crisis of antibiotic resistance intensifying, phage therapy has emerged as a promising targeted antibacterial strategy and is now entering a critical phase of clinical translation.

Scientists Meet in Valencia to Define the Path to Clinical Integration Valencia, Spain. June 9–10, 2026 Researchers, clinicians, and biotechnology innovators from around the world will gather in ...

A bad news day for Trump’s economy, briefly explained Daniel Craig’s daughter shares rare comments about Rachel Weisz 2 women were 'bonding over the beauty of a hike' when they were killed in Utah, ...

Immune checkpoint inhibitors targeting PD-1 and PD-L1 have revolutionized cancer therapy, delivering long-term survival benefits in several malignancies. However, nearly half of patients show limited ...

Central to this evolution is RB-1355, a novel therapeutic comprised of autologous macrophages. Derived from a patient’s own circulating monocytes, these cells undergo a sophisticated transformation ...

While the bacterial microbiome is now recognized as a key hallmark of cancer, the fungal component, the mycobiome, remains a largely unexplored frontier in ...

The interplay between host immunity, the microbiota, and cancer is a rapidly evolving area of immuno-oncology. An increasing body of evidence highlights the ...

The Food and Drug Administration Monday unveiled the details of a new policy designed to make it easier and quicker for patients with very rare diseases to get cutting-edge treatments. The new ...